Massey researchers develop the first cancer health literacy tool
Virginia Commonwealth University (VCU) Massey Cancer Center researchers have developed the first and only tool that can accurately measure cancer health literacy (CHL) and quickly identify patients with limited CHL. This tool has the potential to improve communication and understanding between physicians and patients, which, in turn, could lead to better clinical outcomes.
Massey’s Dalton Oncology Clinic treatment area gets a face-lift
On October 20, VCU Massey Cancer Center opened the doors to its newly renovated treatment area in the Dalton Oncology Clinic, which is located on the ground floor of North Hospital at the VCU Medical Center downtown campus. The renovations were done to improve patient comfort, privacy and safety. The size of the treatment space was enlarged, and it features a fresh design, with soothing colors, updated fixtures and new furniture. The space includes four private treatment rooms as well as an expansive, open room comprised of 20 pods that give each patient a semi-private area with room for a family member or friend. Each pod is equipped with a television, set of headphones and nurse call bell system. More patient bathrooms, physician work rooms and nurse stations were also added.
You’ve got a friend
Kim McGaughey is a four-time cancer survivor. In 2008, she was diagnosed with stage 1B cervical cancer and stage 4 breast cancer. After beating her cervical cancer and getting her breast cancer under control, Kim was blindsided by a cervical cancer recurrence in 2011 that had metastasized to her lungs. Now, in 2014, Kim has just finished chemotherapy for her second recurrence of cervical cancer. For most, a journey like this would make you understandably negative – but not Kim. She and a group of her closest friends turned her daunting, 8-hour chemotherapy infusion treatments into celebrations, which they aptly named “chemo parties.”
Chat on the current state of cancer treatment and research
This past Tuesday ABC News hosted a Twitter chat with the American Association for Cancer Research (AACR) on the current state of cancer following the release of the Cancer Progress Report 2014. Steven R. Grossman, M.D., Ph.D., deputy director of Massey Cancer Center, provided expert commentary as Dr. Richard Besser, ABC News Chief Health/Medical Editor, posed a series of questions and discussion topics.
Study uncovers genetic driver of inflammation, uses it to prevent and treat liver cancer
Inflammation has been shown to be a driving force behind many chronic diseases, especially liver cancer, which often develops due to chronic inflammation caused by conditions such as viral hepatitis or alcoholism and has relatively few effective treatment options. Now, scientists at Virginia Commonwealth University Massey Cancer Center have demonstrated for the first time in preclinical studies that blocking the expression of a gene known as astrocyte elevated gene-1 (AEG-1) halts the development and progression of liver cancer by regulating inflammation. This research could impact not only the treatment of liver cancer, but many inflammation-associated diseases.